SCHEMBL6802333

SCHEMBL6802333

CNC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.56
MMP9 P14780 5/20 0.49
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
RAB9A P51151 1/20 0.49
MMP2 P08253 5/20 0.47
MMP1 P03956 4/20 0.47
MMP13 P45452 3/20 0.47
MMP8 P22894 2/20 0.47
ALDH1A1 P00352 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
KDM1A O60341 1/20 0.47
MAOA P21397 1/20 0.47
MMP3 P08254 2/20 0.46
BCHE P06276 1/20 0.46
ACHE P22303 1/20 0.46
CA2 P00918 3/20 0.46
CA1 P00915 2/20 0.46
CA12 O43570 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6802343 1.00 TDP1 (0.56) TDP1MMP9KMT2AMEN1RAB9A
SCHEMBL6799543 0.91 MMP2 (0.55) MMP9MMP2MMP1MMP13MMP8
SCHEMBL6799552 0.91 MMP2 (0.55) MMP9MMP2MMP1MMP13MMP8
SCHEMBL8141494 0.88 TDP1 (0.72) TDP1MMP9KMT2AMEN1MMP2
SCHEMBL8141491 0.88 TDP1 (0.72) TDP1MMP9KMT2AMEN1MMP2
SCHEMBL6912827 0.88 POLB (0.56) MMP9KMT2AMEN1RAB9AMMP2
SCHEMBL6912842 0.88 POLB (0.56) MMP9KMT2AMEN1RAB9AMMP2
SCHEMBL13956908 0.85 TDP1 (0.60) TDP1MMP9KMT2AMEN1MMP2
SCHEMBL13957019 0.84 MMP9 (0.66) TDP1MMP9MMP2ALDH1A1GAA
SCHEMBL20187255 0.83 TDP1 (0.56) TDP1MMP9KMT2AMEN1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004074238-A1 PHENETHYLAMINO SULFAMIC ACIDS THE PROCTER & GAMBLE COMPANY (US) 2004-09-02 WO disclosed
US-20040167183-A1 Phenethylamino sulfamic acids THE PROCTER & GAMBLE COMPANY 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167183-A1 Phenethylamino sulfamic acids PTPRM, PTPRS, PTPRE TDP1 2860/4885MMP9 2969/4885KMT2A 2262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.